International Pharmaceutical Transparency Act of 2019
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line